Skip to content
Wednesday, February 4, 2026

BLK ALERTS

THE ARCHIVES

  • Home
  • Lifestyle
  • News
  • Crime
  • Entertainment
  • Opinion
  • Sports
  • Politics

As Zepbound shortage grows, Eli Lilly says there’s no immediate end in sight

Posted on April 19, 2024 by blkalertshealth
Zepbound drugmaker Eli Lilly is working to increase its weight loss drug supply. But some steps to get there, including building a new plant, will take months to execute.
Posted in HealthTagged Black Health, black people health, blacknews, CNN, nbcnews, newswirelink, TIME, us health

Post navigation

Previous: Worsening allergies tied to climate change and severe weather
Next: Scotland pauses prescriptions of puberty blockers for transgender minors

Related Posts

  • Health

8 activewear brands you should add to your workout wardrobe

  • blkalertshealth
  • March 23, 2024
  • 0

The increasing popularity of stylish, trendy athle

  • Health

Coronavirus: Health Staff Braced for Expected Covid-19 Surge

  • Alex Haynes
  • January 14, 2021
  • 0

To understand the new smart watched and other pro devices of recent focus, we should look to Silicon Valley and the quantified movement of the […]

  • Health

Study finds a new type of bacteria present in colorectal cancer

  • blkalertshealth
  • March 22, 2024
  • 0

According to a study in the scientific journal Nat

New Comments

  • First Bullet Train Line Approved to Enter Service – BossFM Digital on First Bullet Train Line Approved to Enter Service
  • US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program – BossFM Digital on US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program
  • Moratorium Ending, Millions Face Eviction – BossFM Digital on Moratorium Ending, Millions Face Eviction
  • Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction – BossFM Digital on Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction
Copyright © 2026 BLK ALERTS Theme: Classy News By Adore Themes.